Skip to main content .
img
service-bg

Core Services

BARDA supports a number of core services to assist the production of required products, in a manner that is reliable and cost effective.

Influenza

BARDA uses a strategic portfolio approach to develop and acquire a broad array of medical countermeases for pandemic influenza.

Innovation

BARDA's innovation programs support the advancement of platform technologies that enhance capabilities of medical countermeasures.

Emerging Infectious Diseases

Support the rapid development of multi-purpose products, platforms, facilities, and countermeasures

CBRN Programs

The Pandemic and All Hazards Preparedness Act (PAHPA) established BARDA as the focal point for the advanced development and acquisition of medical countermeasures.

Stockpile Building

Congress seeks to improve our Nation's emergency preparedness with Project BioShield.

Newsroom

Latest announcements related to medical countermeasures

HHS, DOD collaborate with Johnson & Johnson to produce millions of COVID-19 investigational vaccine doses

The U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD) announced an agreement with the Janssen Pharmaceutical Companies of Johnson & Johnson, to demonstrate large-scale manufacturing and delivery of the company’s COVID-19 vaccine candidate. Under the terms of the agreement, the federal government will own the resulting 100 million doses of vaccine.

Full Announcement

Website Refresh

www.medicalcountermeasures.gov is pleased to announce a phased launch of our newly redesigned public website. We are making website improvements to provide a more modern and customer-centric web experience. Over the next several months you will see differences throughout the site while we continue implementing updates. Thank you for your understanding and please let us know if you have any questions: techwatchinbox@hhs.gov